RWM
VYGR icon

Ritholtz Wealth Management’s Voyager Therapeutics VYGR Stock Holding History

Ritholtz Wealth Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,556
Closed -$91.4K – 921
2024
Q2 		$91.4K Sell
11,556
-3,841
-25% -$32.2K ﹤0.01% 806
2024
Q1 		$143K Sell
15,397
-4,362
-22% -$36.8K ﹤0.01% 760
2023
Q4 		$167K Buy
19,759
+2,089
+12% +$15.2K 0.01% 710
2023
Q3 		$137K Buy
+17,670
New +$161K 0.01% 666

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ritholtz Wealth Management's VYGR Position: Q3 2024 in Review

Ritholtz Wealth Management sold out of Voyager Therapeutics (VYGR) in Q3 2024, closing a stake of 11,556 shares — an estimated $91.4K sold.

Ritholtz Wealth Management first reported a position in VYGR in Q3 2023 and held it in 4 quarters. The position peaked at $167K in Q4 2023. 128 funds tracked by Wall St. Rank hold VYGR as of Q3 2024.

  • Ritholtz Wealth Management reported no remaining Voyager Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Ritholtz Wealth Management sold 11,556 Voyager Therapeutics shares in Q3 2024, an estimated $91.4K.
  • Ritholtz Wealth Management first reported a position in Voyager Therapeutics in Q3 2023 and held it in 4 quarters.
  • Ritholtz Wealth Management's Voyager Therapeutics position peaked at $167K in Q4 2023.
  • 128 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2024.

Based on Ritholtz Wealth Management's 13F filing for Q3 2024, filed 10 Oct 2024.